Quotient Clinical is a provider of early stage outsourced drug development services to the pharmaceutical and biotechnology industries.
Headquartered in Nottingham in the UK, Quotient has developed a platform which offers an integrated approach to formulation development, "real-time" drug product manufacturing and clinical testing. Using this platform has been proven to significantly reduce the time and cost of the early stage drug development process. It has two operational facilities in the UK. The company operates two facilities: in Nottingham, which has a certified 85 bed clinical pharmacology unit with an integrated drug manufacturing facility employing formulation chemists, and clinical staff including nurses and doctors; and in Edinburgh which houses the companies' Biometrics function responsible for the analysis and reporting of clinical trial data.
In December 2015 the company was sold to GHO Capital in a transaction which saw Bridgepoint Development Capital make a strong return on its investment.
To learn more about the company, visit www.quotientclinical.com